|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: WHI & HRTFrom: Betsy Hyde (elishyde@mindspring.com)Tue Jul 9 17:47:02 2002
At 2:55 PM 7/9/02, Douglas Krell wrote: >Patients will still have concerns about vasomotor symptoms and the >prevention of osteoporosis. So as long as vasomotor sympotms persist, the >products can be used then abandoned as soon as possible. I have many of my >HRT patients on low dose Aspirin and or a statin drug. Pravachol ois the >only one that does not require LFT monitoring. As for osteoporosis >prevention and treatment, there are great drugs for that. Evista, early on, >then later bisphosphonates I think that is the take home message that is coming out these days...use short-term estrogen for symptom relief, and treat the other stuff (BMD, cardiac disease) with something which is more specific, more effective. Isn't the WHI data the first to suggest reduction of fractures vs increase in BMD which most of the other studies have used as an endpoint? I think the SERMs are looking a lot better....
-- Betsy Hyde CNM
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Dec 2 04:53:43 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.